PMA Required For OvaCheck Software, FDA Tells Correlogic
Correlogic plans to pull OvaCheck software from lab facilities and do the analysis in-house to avoid FDA regulation of the firm's ovarian cancer blood test
Correlogic plans to pull OvaCheck software from lab facilities and do the analysis in-house to avoid FDA regulation of the firm's ovarian cancer blood test